SUBSCRIBE
SUBSCRIBE
News   Business

Micrus Endovascular Corporation Fiscal Fourth Quarter Neurovascular Revenues Increase 24% to $25.6 Million

May 6, 2010 | 
1 min read
SAN JOSE, Calif.--(BUSINESS WIRE)--Micrus Endovascular Corporation (Nasdaq: MEND) today reported financial results for the three and 12 months ended March 31, 2010 and introduced fiscal 2011 financial guidance.
Earnings
MORE ON THIS TOPIC
Hands reach out to each other. Handshake. Halftone retro hands. Body parts cut out of newspaper. Hands tied with thread. Shaking hands. Make a deal. Successful agreement. Modern collage
Mergers & acquisitions
Ipsen Puts Up $1.6B To Absorb ImCheck for Mid-Stage Leukemia Antibody
October 22, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Corporate headquarters of Novo Nordisk in Denmark
C-suite
Novo Foundation Replaces Pharma’s Board, Revealing Deep Divisions Over Leadership
October 21, 2025
 · 
4 min read
 · 
Annalee Armstrong
Business people and concepts vector art exit
Cell therapy
Galapagos Exits Cell Therapy, Cuts 365 Employees
October 21, 2025
 · 
2 min read
 · 
Tristan Manalac
Hand holding a lung shape symbol against a blue background. World tuberculosis day, world no tobacco day, lung cancer, pulmonary hypertension, pneumonia
Lung cancer
Summit Eyes 2025 FDA Application for Ivonescimab Despite Overall Survival Miss
October 21, 2025
 · 
2 min read
 · 
Tristan Manalac